Exchange: NASDAQ·Updated 04:18 PM EDT

About

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
37

Frequently Asked Questions

What is Market Cap of Corvus Pharmaceuticals Inc?
What is the 52-week high for Corvus Pharmaceuticals Inc?
What is the 52-week low for Corvus Pharmaceuticals Inc?
What is Corvus Pharmaceuticals Inc stock price today?
What was Corvus Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Corvus Pharmaceuticals Inc?
What is the Price-to-Book ratio of Corvus Pharmaceuticals Inc?
What is the 50-day moving average of Corvus Pharmaceuticals Inc?
How many employees does Corvus Pharmaceuticals Inc have?

Advertisement|Remove ads.